Results 61 to 70 of about 4,013 (114)

Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation. [PDF]

open access: yesCirculation, 2023
Gordon LB   +10 more
europepmc   +1 more source

Lonafarnib Clinical Trials Demonstrate Uncoupling of the Muscle-Bone Unit in Hutchinson-Gilford Progeria Syndrome. [PDF]

open access: yesJ Bone Miner Res
Kreienkamp RJ   +8 more
europepmc   +1 more source

Author Correction: Unique progerin C-terminal peptide ameliorates Hutchinson-Gilford progeria syndrome phenotype by rescuing BUBR1. [PDF]

open access: yesNat Aging, 2023
Zhang N   +10 more
europepmc   +1 more source

Impact of miR-181a on SIRT1 Expression and Senescence in Hutchinson-Gilford Progeria Syndrome. [PDF]

open access: yesDiseases
Lederer EM   +5 more
europepmc   +1 more source

Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome. [PDF]

open access: yesGeroscience, 2023
Díez-Díez M   +12 more
europepmc   +1 more source

National survey of Hutchinson-Gilford progeria syndrome and progeroid laminopathy in Japan. [PDF]

open access: yesAging (Albany NY)
Okawa Y   +20 more
europepmc   +1 more source

Lonafarnib improves cardiovascular function and survival in a mouse model of Hutchinson-Gilford progeria syndrome. [PDF]

open access: yesElife, 2023
Murtada SI   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy